Skip to content

Biote Corp. BTMD Shares (Basic)

Shares (Basic) at other companies

Target logo
TargetTGT
453.8M-0.3%
Walmart
 logo
Walmart WMT
8B-0.5%
Lifecore Biomedical, Inc. logo
Lifecore Biomedical, Inc.LFCR
37.5M+7.6%
BioLife Solutions logo
BioLife SolutionsBLFS
48.5M+2.8%
NAG
Niagen Bioscience, Inc. Common StockNAGE
79.9M+2.7%
Lifevantage Corporation logo
Lifevantage CorporationLFVN
12.6M+2.2%

Other financials

Income statement

See full
Revenue$44.9M-8.3%
Gross profit$31.0M-14.9%
Operating income$3.2M-67.3%
Net income$2.3M-83.4%
EPS (diluted)$0.06-83.8%

Balance sheet

See full
Cash & equivalents$5.3M-87.2%
Total debt$103.4M-5.5%
Total equity-$56.1M+37.7%
Total assets$89.0M-27.8%

Cash flow

See full
Operating cash flow$3.9M-39.7%
CapEx$362.0K-77.8%
Free cash flow$3.5M-26.8%

Valuation

See full
Market cap$57.33M-51.2%
Enterprise value$155.43M-26.5%
P/E3.7×-0.1×
P/S0.3×-0.3×

Profitability

See full
Gross margin70.1%-1.2pp
Operating margin15.4%-0.1pp
Net margin8.3%-2.3pp
FCF margin15.3%-3.2pp

Returns & leverage

See full
Return on equity-21.4%
Debt / equity9.1×
Current ratio1.3×-0.1×

Where this comes from

Reported directly by Biote Corp. in its filing.

Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfSharesOutstandingBasic.

The official record: Biote Corp.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Biote Corp.'s shares (basic).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Biote Corp.'s shares (basic)?
Biote Corp. (BTMD) reported shares (basic) of 30.6M in Q1 2026.
How has Biote Corp.'s shares (basic) changed year-over-year?
Biote Corp.'s shares (basic) decreased by 2.7% year-over-year, from 31.5M to 30.6M.
What is the long-term trend for Biote Corp.'s shares (basic)?
Over 2 years (2023 to 2025), Biote Corp.'s shares (basic) has grown at a 15.4% compound annual growth rate (CAGR), from 94.3M to 125.7M.
What does shares (basic) mean?
The time-weighted average number of common shares outstanding during the period, used as the denominator for basic EPS calculations.